Citizens Financial Group Inc. RI Has $294,000 Stock Position in Agilent Technologies, Inc. $A

Citizens Financial Group Inc. RI raised its stake in Agilent Technologies, Inc. (NYSE:A) by 25.3% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,493 shares of the medical research company’s stock after acquiring an additional 503 shares during the quarter. Citizens Financial Group Inc. RI’s holdings in Agilent Technologies were worth $294,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of the stock. Brighton Jones LLC increased its holdings in shares of Agilent Technologies by 6.1% in the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock valued at $626,000 after purchasing an additional 270 shares in the last quarter. Teachers Retirement System of The State of Kentucky boosted its position in Agilent Technologies by 2.8% in the 1st quarter. Teachers Retirement System of The State of Kentucky now owns 22,178 shares of the medical research company’s stock valued at $2,595,000 after buying an additional 613 shares during the last quarter. Lindbrook Capital LLC boosted its position in Agilent Technologies by 16.0% in the 1st quarter. Lindbrook Capital LLC now owns 1,929 shares of the medical research company’s stock valued at $226,000 after buying an additional 266 shares during the last quarter. Obermeyer Wealth Partners increased its stake in shares of Agilent Technologies by 42.8% in the 1st quarter. Obermeyer Wealth Partners now owns 2,870 shares of the medical research company’s stock valued at $336,000 after buying an additional 860 shares during the period. Finally, Universal Beteiligungs und Servicegesellschaft mbH increased its stake in shares of Agilent Technologies by 5.7% in the 1st quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 365,725 shares of the medical research company’s stock valued at $42,783,000 after buying an additional 19,592 shares during the period. 87.41% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, CEO Padraig Mcdonnell sold 12,490 shares of the company’s stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $150.00, for a total value of $1,873,500.00. Following the completion of the transaction, the chief executive officer owned 33,448 shares in the company, valued at $5,017,200. This represents a 27.19% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.26% of the company’s stock.

Agilent Technologies Stock Performance

Shares of Agilent Technologies stock opened at $144.62 on Thursday. The stock’s fifty day simple moving average is $138.72 and its 200 day simple moving average is $124.66. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53. The company has a market capitalization of $41.00 billion, a PE ratio of 33.95, a PEG ratio of 4.67 and a beta of 1.29. Agilent Technologies, Inc. has a 12 month low of $96.43 and a 12 month high of $153.84.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.37. The company had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The company’s revenue for the quarter was up 10.1% compared to the same quarter last year. During the same period in the prior year, the company earned $1.32 earnings per share. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, research analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 28th. Investors of record on Tuesday, January 6th will be paid a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, January 6th. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.25. Agilent Technologies’s dividend payout ratio (DPR) is currently 23.24%.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on A shares. UBS Group raised Agilent Technologies from a “neutral” rating to a “buy” rating and upped their price target for the company from $130.00 to $170.00 in a research note on Wednesday, October 8th. Rothschild & Co Redburn began coverage on shares of Agilent Technologies in a research report on Wednesday, October 8th. They set a “buy” rating and a $165.00 target price on the stock. Evercore ISI lifted their price target on shares of Agilent Technologies from $128.00 to $140.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 7th. TD Cowen boosted their price target on shares of Agilent Technologies from $150.00 to $162.00 and gave the stock a “buy” rating in a research note on Tuesday, October 14th. Finally, Robert W. Baird increased their price objective on shares of Agilent Technologies from $141.00 to $142.00 and gave the company an “outperform” rating in a report on Thursday, August 28th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $149.62.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.